With an ever-ageing population, the incidence of hip fractures is increasing worldwide. Increasing age is not just associated with increasing fractures but also increasing comorbidities and polypharmacy. Consequently, a large proportion of patients requiring hip fracture surgery (HFS) are also prescribed antiplatelet and anti-coagulant medication. There remains a clinical conundrum with regards to how such medications should affect surgery, namely with regards to anaesthetic options, timing of surgery, stopping and starting the medication as well as the need for reversal agents. Herein, we present the up-to-date evidence on HFS management in patients taking blood-thinning agents and provide a summary of recommendations based on the existing literature.

中文翻译：

---

服用抗凝剂的患者股骨近端骨折：有什么变化吗？

随着人口的不断老龄化，髋部骨折的发病率在全球范围内呈上升趋势。年龄的增长不仅与骨折的增加有关，而且与合并症和多种药物的使用有关。因此，很大一部分需要髋部骨折手术 (HFS) 的患者还开具了抗血小板和抗凝药物。关于此类药物如何影响手术仍然存在临床难题，即关于麻醉选择、手术时间、停止和开始药物治疗以及对逆转剂的需求。在此，我们提供了有关服用血液稀释剂的患者 HFS 管理的最新证据，并根据现有文献提供了建议摘要。